Drugs / CARBASPIRIN
CARBASPIRIN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT02565693 | Sep 2014 → Jan 2021 | atrial fibrillation, intracerebral hemorrhage | UMC Utrecht | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT07486570 Background | Feb 2026 → Feb 2028 expected | vascular insufficiency disorder | Medisch Spectrum Twente | Recruiting | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CARBASPIRIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833404 ↗ |
| Known as | Calcium acetylsalicylate complex with urea | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833404 ↗ |
| Known as | Calcium carbaspirin | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833404 ↗ |
| Known as | Carbasalate | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833404 ↗ |
| Known as | Carbasalate calcique | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833404 ↗ |
| Known as | Carbasalate calcium | “Patients in both study groups receive mono antiplatelet therapy with carbasalate calcium (100 mg daily).” NCT07486570 ↗ |
| Known as | Carbasalato calcico | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833404 ↗ |
| Known as | CARBASPIRIN CALCIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL3833404 ↗ |
| Modality | Small molecule | — CHEMBL3833404 ↗ |